authors
- Tutt, ANJ
- Garber, J
- Gelber, RD
- Phillips, K-A
- Eisen, Andrea
- Johannsson, OT
- Rastogi, P
- Cui, KY
- Im, S-A
- Yerushalmi, R
- Brufsky, AM
- Taboada, M
- Rossi, G
- Yothers, G
- Singer, C
- Fein, LE
- Loman, N
- Cameron, D
- Campbell, C
- Geyer, CE
VP1-2022: Pre-specified event driven analysis of Overall Survival (OS) in the OlympiA phase III trial of adjuvant olaparib (OL) in germline BRCA1/2 mutation (gBRCAm) associated breast cancer
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- May 2022
has subject area
- 1112 Oncology and Carcinogenesis (FoR)
- Oncology & Carcinogenesis (Science Metrix)
published in
- Annals of Oncology Journal